**MDL Development Team**

Currently Active Developers, and their roles, principle expertise in
developing MDL

-   Nick Holford (University of Auckland; Uppsala University) : MDL
    lead, pharmacometric concepts, pharmacology, modelling and
    simulation tasks, use case development, NONMEM, NM-TRAN to MDL
    conversion.

-   Mike K Smith (Pfizer) : MDL co-lead, documentation, ddmore R package
    lead, interoperability, model-based drug development, Pharma
    industry perspective, statistical concepts, use case development,
    grammar.

-   Stuart Moodie (Eight Pillars Ltd / Pfizer) : Language design and
    implementation, MDL-IDE development, conversion to PharmML

-   Maciej Swat (EMBL-EBI) : PharmML lead

-   Florent Yvon (EMBL-EBI) : libPharmML lead

-   Emmanuelle Comets (INSERM) : Design Object, Optimal Design task
    specification.

-   Paolo Magni (Università degl Studi di Pavia) : Prior Object
    definition, Bayesian Use Cases, BUGS lead.

-   Elisa Borella, Letizia Carrara, Cristiana Larizza, Lorenzo Pasotti,
    (Università degl Studi di Pavia) : BUGS conversion, BUGS connector,
    Bayesian Use Cases.

-   Zinnia Parra-Guillén (Universidad de Navarra; Freie Universität
    Berlin) : Training material, documentation, Use Case specification
    and testing.

-   Niklas Hartung (Freie Universität Berlin) : Use Case specification,
    testing, Monolix.

-   Niels Rode-Kristensen (Novo Nordisk) : Interoperability lead

-   Richard Kaye (Mango Solutions) : Integration Framework technical
    lead, SEE builds

-   Gareth Smith (Cyprotex) : Common converter

-   Henrik Bjugård Nyberg (Mango Solutions / Uppsala University) :
    PharmML to NM-TRAN translation

-   Eric Blaudez (Lixoft) : PharmML to MLXTRAN conversion.

-   Nadia Terranova (Merck Serono S.A., a Subsidiary of Merck KGaA) :
    Standard Output object definition

-   Rikard Nordgren (Uppsala University) : NONMEM to Standard Output
    object translation, PopED conversion.

-   Kajsa Harling (Uppsala University) : PsN translation and integration

-   Chris Muselle (Mango Solutions) : ddmore R package developer

**MDL Contributors**

These individuals have made important contributions to MDL and
associated deliverables. In alphabetical order:

-   *Roberto Bizzotto (CNR Institute of Neurosciences)*

-   *Letizia Carrara (Uni di Pavia)*

-   *Phylinda Chan (Pfizer)*

-   *Marylore Chenel (Servier)*

-   *Ronald Gieschke (Roche)*

-   *Lutz Harnisch (Pfizer)*

-   *Andrew Hooker (Uppsala University)*

-   *Mats Karlsson (Uppsala University)*

-   *Charlotte Kloft (Freie Universität Berlin)*

-   *Natallia Kokash (Leiden Unversity; UCL, London)*

-   *Marc Lavielle (INRIA)*

-   *Guilia Lestini (INSERM, Paris)*

-   *Andrea Mari (CNR Institute of Neurosciences)*

-   *France Mentré (INSERM)*

-   *Mateusz Rogalski (Mango Solutions)*

-   *Maria-Luisa Sardu (Merck Serono S.A., a Subsidiary of Merck KGaA)*

-   *Gunnar Yngman (Uppsala University)*

**DDMoRe**

[www.ddmore.eu](http://www.ddmore.eu)

**Report bugs, problems with MDL, ddmore R package, MDL-IDE, Integration
Framework (SEE)**

[http://www.ddmore.eu/forum](http://www.ddmore.eu/forum)

**FAQ about DDMoRe**

[http://www.ddmore.eu/faq](http://www.ddmore.eu/faq)

**Download MDL-IDE software:**

[https://sourceforge.net/projects/ddmore/files/install/SEE/](https://sourceforge.net/projects/ddmore/files/install/SEE/)

**PharmML**

[http://www.pharmml.org/](http://www.pharmml.org/)
